The joint statement, which follows the recent recommendations published by the National Commission into the Regulation of AI in Healthcare, commits jointly developing a set of high-level principles to guide how they will regulate the use of AI by health and social care professionals across the UK.

PSA chair, Caroline Corby, said: ‘Effective regulation can't be developed in isolation, and the Commission's report rightly recognises the need for co-ordination across the regulatory landscape. Through our work convening health and care professional regulators and Accredited Registers on AI, the PSA has seen first-hand the value of collaboration and shared learning.

‘Confidence by the public and professionals in the benefits of AI rests on appropriate safeguards, accountability and consistency in expectations about how it is used. By working together, we can take a preventative approach to regulation that supports innovation while maintaining professional standards.'

The statement is an early result of work by the PSA and the Medicines and Healthcare products Regulatory Agency on co-chairing a dedicated Task and Finish Group that brings together professional regulators and the Accredited Registers Collaborative.